Dr. Harker-Murray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
# Division
Milwaukee, WI 53226Phone+1 414-805-6800Fax+1 414-805-0352
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2002 - 2005
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1999 - 2002- Mayo Clinic College of MedicineClass of 1999
Certifications & Licensure
WI State Medical License 2005 - 2025
TX State Medical License 2007 - 2014
MN State Medical License 2000 - 2011
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery Start of enrollment: 2013 Jul 31
- A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
- Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 May 17
Publications & Presentations
PubMed
- 2 citationsClinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma.Sherréa Jones, Valencia Henry, Erin Strong, Salma A Sheriff, Karolyn Wanat
The Journal of Surgical Research. 2023-06-01 - Xanthomatous Dermal Changes in a Patient With Locally Advanced Basal Cell Carcinoma Treated Using Vismodegib.Shane D B Smith, Callisia N Clarke, Melanie A. Clark, Amy K. Harker-Murray, Olayemi Sokumbi
The American Journal of Dermatopathology. 2021-08-01 - 75 citationsContinuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trialAlain Algazi, Megan Othus, Adil Daud, Roger S. Lo, Janice M. Mehnert
Nature Medicine. 2020-10-05
Press Mentions
Family Inspired to Make a DifferenceJune 14th, 2022
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
